Captrust Financial Advisors Harrow Health, Inc. Transaction History
Captrust Financial Advisors
- $30.9 Billion
- Q2 2024
A detailed history of Captrust Financial Advisors transactions in Harrow Health, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 93,954 shares of HROW stock, worth $4.89 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
93,954
Previous 93,944
0.01%
Holding current value
$4.89 Million
Previous $1.24 Million
57.97%
% of portfolio
0.01%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding HROW
# of Institutions
146Shares Held
20.5MCall Options Held
700KPut Options Held
564K-
Opaleye Management Inc. Boston, MA3.99MShares$208 Million21.35% of portfolio
-
Private Capital Management, LLC Naples, FL2.71MShares$141 Million7.1% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$112 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.84MShares$95.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA723KShares$37.6 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.41B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...